For laboratory research only. Not for human or animal use. This article gives no dosing, administration or therapeutic advice.
Short answer: Kisspeptin and hCG sit at different levels of the reproductive axis. Kisspeptin is a hypothalamic peptide that acts on GnRH neurons through KISS1R and so drives LH and FSH release from the pituitary[1][2]. hCG is a gonadotropin that acts lower down, on the same LH/hCG receptor (LHCGR) that LH uses in Leydig, theca and granulosa cells[9][8]. One is a signal to the brain’s GnRH pulse generator. The other is a signal to the gonad. This difference decides which one a given experiment needs. For laboratory work with the upstream peptide, see our kisspeptin 10mg research vial.
Where each one acts
Kisspeptin’s main route is through GnRH. Its receptor sits on GnRH neurons, and kisspeptin given to mice lacking the receptor had no effect on LH or FSH[2]. A GnRH antagonist blocked kisspeptin’s LH response in mice[3]. hCG does not need GnRH: it binds LHCGR directly on gonadal cells, and the LH receptor is required for ovulation in females and for Leydig-cell development in males[7].
| Kisspeptin | hCG | |
|---|---|---|
| Class | RF-amide peptide; kisspeptin-10 is the active C-terminal decapeptide[1] | Glycoprotein hormone, an LH agonist in humans[9] |
| Receptor | KISS1R (GPR54), a GPCR on GnRH neurons[2] | LHCGR, a GPCR in testis Leydig cells and ovarian theca, luteal and granulosa cells[9] |
| Position in the axis | Upstream of GnRH | Downstream of the pituitary |
| Loss of function | Kiss1-null mice stay sexually immature with low gonadotropins and sex steroids[4] | Inactivating LHB and LHCGR mutations cause hypogonadism[9] |
For the full picture of how kisspeptin and GnRH divide the work, see kisspeptin vs GnRH.
hCG and LH share a receptor, but are not identical
LH and hCG are close in structure and bind the same receptor. Reviews note that they nonetheless differ in downstream signalling, so they are not as interchangeable as once thought[8]. The receptor itself has been mapped in detail, along with its regulation[7]. Knockout mice with inactivated LHR have been central to understanding gonadal development[9].
What kisspeptin experiments measure
Kisspeptin work reads out the pituitary and the neuron: LH and FSH rise after kisspeptin, GnRH release into cerebrospinal fluid in sheep, and blocked responses with a GnRH antagonist[2][3]. In healthy men, intravenous kisspeptin-10 raised LH in a dose-dependent way and increased LH pulse frequency[5]. In a small crossover study, kisspeptin-54 raised LH, FSH and testosterone in men[6]. These are signals that pass through the whole axis. A hCG experiment skips the first two steps and reads out gonadal responses instead, such as receptor signalling and steroid output.
Where the two meet in the literature
The best-known meeting point is ovulation triggering in assisted reproduction research, where hCG has been the standard trigger. Clinical trials have tested kisspeptin-54 as an alternative that works through the LH surge instead of acting on the ovary directly. A 2014 study of 53 women reported egg maturation at each dose tested[10]. A later phase 2 trial in women at high risk of ovarian hyperstimulation reported oocyte maturation in 95% of participants[11]. A comparison of granulosa cells found that kisspeptin-54 triggering changed expression of ovarian steroidogenic genes compared with traditional triggers[12]. These are records of regulated clinical studies. They are not claims about research-grade material and they carry no advice on use.
Which fits which question?
- GnRH neuron activation and pulse frequency: kisspeptin[2][5].
- Puberty-onset models and KISS1R genetics: kisspeptin[4].
- Gonadal LHCGR signalling and steroidogenesis: hCG or LH[7][8].
- Ovulation-trigger comparisons: both, in the context of the clinical studies cited above[10][12].
The kisspeptin-10 research guide covers the peptide’s structure and models, and our kisspeptin research page lists the product. SPO does not sell hCG. For the rest of the range, see our guide to buy peptides online in Canada.
Frequently asked questions
What is the difference between kisspeptin and hCG?
Kisspeptin is a hypothalamic peptide that acts on KISS1R on GnRH neurons and so drives LH and FSH release. hCG is a gonadotropin that acts on the LH/hCG receptor in the gonads.
Do kisspeptin and hCG use the same receptor?
No. Kisspeptin uses KISS1R (GPR54). hCG uses the LH/hCG receptor (LHCGR), the same receptor LH uses.
Does kisspeptin need GnRH to raise LH?
In mice, a GnRH antagonist blocked kisspeptin’s LH response, which places kisspeptin upstream of GnRH.
Why are kisspeptin and hCG compared in IVF research?
hCG has been the usual trigger for oocyte maturation. Clinical trials have tested kisspeptin-54 as a trigger that works through the LH surge, so the two are compared in that setting.
Does Shop Peptides Online sell hCG?
No. SPO lists kisspeptin-10 for laboratory research only, not for human or animal use. hCG is not in the catalogue.
References
- Kotani M, Detheux M, Vandenbogaerde A et al. (2001). The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem. PMID: 11457843. doi: 10.1074/jbc.M104847200.
- Messager S, Chatzidaki EE, Ma D et al. (2005). Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc Natl Acad Sci U S A. PMID: 15665093. doi: 10.1073/pnas.0409330102.
- Gottsch ML, Cunningham MJ, Smith JT et al. (2004). A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology. PMID: 15217982. doi: 10.1210/en.2004-0431.
- d’Anglemont de Tassigny X, Fagg LA, Dixon JP et al. (2007). Hypogonadotropic hypogonadism in mice lacking a functional Kiss1 gene. Proc Natl Acad Sci U S A. PMID: 17563351. doi: 10.1073/pnas.0704114104.
- George JT, Veldhuis JD, Roseweir AK et al. (2011). Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. J Clin Endocrinol Metab. PMID: 21632807. doi: 10.1210/jc.2011-0089.
- Dhillo WS, Chaudhri OB, Patterson M et al. (2005). Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab. PMID: 16174713. doi: 10.1210/jc.2005-1468.
- Ascoli M, Fanelli F, Segaloff DL (2002). The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev. PMID: 11943741. doi: 10.1210/edrv.23.2.0462.
- Choi J, Smitz J (2014). Luteinizing hormone and human chorionic gonadotropin: origins of difference. Mol Cell Endocrinol. PMID: 24365330. doi: 10.1016/j.mce.2013.12.009.
- Huhtaniemi IT (2026). Luteinizing hormone receptor knockout mouse: What has it taught us?. Andrology. PMID: 39840520. doi: 10.1111/andr.70000.
- Jayasena CN, Abbara A, Comninos AN et al. (2014). Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. J Clin Invest. PMID: 25036713. doi: 10.1172/JCI75730.
- Abbara A, Jayasena CN, Christopoulos G et al. (2015). Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy. J Clin Endocrinol Metab. PMID: 26192876. doi: 10.1210/jc.2015-2332.
- Owens LA, Abbara A, Lerner A et al. (2018). The direct and indirect effects of kisspeptin-54 on granulosa lutein cell function. Hum Reprod. PMID: 29206944. doi: 10.1093/humrep/dex357.
